Astonea Labs Ltd

Astonea Labs Ltd

$ASTONEALABPharmaceuticalsBSE

Astonea Labs Ltd (ASTONEALAB) last traded at ₹274, a market capitalisation of ₹288 crore, on a P/E of 63.7. Over the past 52 weeks the stock has ranged between ₹118 and ₹301. Astonea Labs Ltd last reported results for the quarter ended Mar 2026, with sales of ₹81 crore and net profit of ₹3 crore. Figures are as of 25 Aug 2026 and are not real time.

Astonea Labs Ltd share price and key metrics

Current price
₹274
Market cap
₹288 cr
Stock P/E
63.7
Book value
₹54.4
ROE
12.0%
ROCE
10.5%
Dividend yield
0.00%
52w high / low
301/118

Metrics as of 25 Aug 2026. Not real time.

Astonea Labs Ltd quarterly results

Astonea Labs Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Sep 2025Mar 2026
Sales476681
Expenses416173
Operating profit758
OPM %14%8%10%
Other income000
Interest222
Depreciation223
Profit before tax324
Tax %24%20%20%
Net profit213
EPS (₹)2.761.352.95

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Astonea Labs Ltd annual results

Astonea Labs Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales30678098148
Operating profit67121514
OPM %19%11%15%16%9%
Net profit01455
EPS (₹)0.621.685.366.934.30

TTM is the trailing twelve months to the most recent quarter.

Astonea Labs Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
%
3 Years
30%
TTM
51%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
97%
TTM
-16%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
55%
Return on Equity
10 Years
%
5 Years
19%
3 Years
22%
Last Year
12%

Astonea Labs Ltd shareholding pattern

Promoters held 72.30% at Mar 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 0.07%.

Astonea Labs Ltd shareholding pattern by quarter, in percent
% heldJun 2025Sep 2025Mar 2026
Promoters72.30%72.30%72.30%
FIIs8.01%2.51%0.00%
DIIs4.55%0.35%0.07%
Public15.15%24.84%27.62%
No. of shareholders1,014437376

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Astonea Labs Ltd corporate filings

  • Approval of Alteration in Object Clause of the Memorandum of Association ("MOA") of the CompanyCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Astonea Labs Ltd has formally approved the alteration of the Object Clause in its…

    Read the full analysis
  • Re-appointment of Ms. Pooja Singh as Director of the CompanyCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Astonea Labs Limited has formally announced the re-appointment of Ms. Pooja Singh as a…

    Read the full analysis
  • Scrutinizer''s Reports and Voting Results of the 9th Annual General Meeting ("AGM") of the Company held on 21st August, 2026AGM/EGMmedium impact
    Filing PDF

    Cruxal's analysis: Astonea Labs Limited has successfully concluded its 9th Annual General Meeting, securing…

    Read the full analysis
  • Proceedings of 9th Annual General Meeting ("AGM") of the Company for the financial year 2025-26 held on 21st August, 2026AGM/EGMmedium impact
    Filing PDF

    Cruxal's analysis: Astonea Labs Limited successfully held its 9th Annual General Meeting, marking its first…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Astonea Labs Ltd

Cruxal reads every Astonea Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.